Point of Care Molecular Diagnostics Market Report 2023 (Global Edition)

Global Point of Care Molecular Diagnostics Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Point of Care Molecular Diagnostics Industry growth. Point of Care Molecular Diagnostics market has been segmented with the help of its By Product, By Technology By Application, and others. Point of Care Molecular Diagnostics market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

Report scope is customizable as we have a huge database of Point of Care Molecular Diagnostics industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.

Assays and Kits segment held the major market share of Point-of-Care Molecular Diagnostics Market

Assays and kits segment held the major market share of Point-of-Care Molecular Diagnostics Market owing to increasing use of this products in the laboratory to research drugs and increasing need for quick and accurate testing is supporting the market growth.

• Assays & Kits
• Analyzers
• Software & Services

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Point of Care Molecular Diagnostics Industry. Request a Free Sample PDF!

PCR based technology segment dominates the Point-of-Care Molecular Diagnostics Market.

Based on Technology, PCR based technology segment held the major share of the Point-of-Care Molecular Diagnostics market in the year 2022 owing to increasing demand for RT-PCR tests for infectious diseases.

• PCR-based
• Genetic Sequencing-based
• Hybridization-based
• Microarray-based

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Point of Care Molecular Diagnostics market report 2023 Edition by contacting our team.

Point of Care Molecular Diagnostics By Application Segment Analysis

Infectious diseases segment dominated the Point-of-Care Molecular Diagnostics Market

Based on application, infectious diseases segment held the largest market share owing to growing prevalence of infectious diseases and demand for Point-of-Care Molecular Diagnostics for the detection of diseases such as COVID-19 which requires rapid and accurate diagnosis to manage infectious diseases and improving patient outcomes.

• Infectious Diseases
• Oncology
• Hematology
• Prenatal Testing
• Endocrinology
• Other Applications

Point of Care Molecular Diagnostics By Test Location Segment Analysis

POC test location segment held the significant share of the Point-of-Care Molecular Diagnostics market.

Based on Test Location, POC test location segment held a significant share of the market. This is attributed to the growing adoption of POC tests across hospitals, clinics, and ambulatory centres.

• OTC
• POC

Point of Care Molecular Diagnostics By End-Use Segment Analysis

The Decentralized Labs segment dominated the Point-of-Care Molecular Diagnostics market

Based on End-Use, the Decentralized Labs segment dominated the market owing to Point-of-Care Molecular Diagnostics test ability to provide rapid and accurate diagnosis and availability of centralized testing and established penetration of centralized testing supports the segment growth.

• Decentralized Labs
• Hospitals
• Homecare
• Assisted Living Healthcare Facilities
• Others

North America is a leading region of the Point-of-Care Molecular Diagnostics market

North America accounted for the major market share in the year 2022 owing to growing geriatric population, increasing healthcare expenditure and increasing demand for new technologies. This is driving the Point-of-Care Molecular Diagnostics market in this region. Moreover, increasing research and development spending and rising government support is projected to increase the growth of the Point-of-Care Molecular Diagnostics Market.

Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

News:

ABBOTT Launched Molecular Point-Of-Care Test to Detect Novel Coronavirus in As Little as Five Minutes

In March 2020, Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the company's ID NOW platform, providing rapid results in a wide range of healthcare settings such as physicians' offices, urgent care clinics and hospital emergency departments.

Top Companies Market Share in Point of Care Molecular Diagnostics Industry: (In no particular order of Rank)

• Abbott Laboratories Bayer Healthcare
• F. Hoffmann La Roche AG
• Becton Dickinson and Company
• BioMerieux
• Bio Rad Laboratories Inc.
• Cepheid Inc.
• Danaher Corporation
• Johnson and Johnson
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..